Published date: 4 November 2019

Withdrawn future opportunity


Approach to market date: 1 February 2020

Contract summary

Industry

  • Blood products - 33141510

Location of contract

Any region

Value of contract

£15,000,000

Procurement reference

CM/PHS/17/5551

Published date

4 November 2019

Approach to market date

1 February 2020

Contract start date

1 July 2020

Contract end date

30 June 2021

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Human Cell Line Recombinant Factor VIII

More information

Previous notice about this procurement

Specialised - Human Cell Line Recombinant Factor VIII

  • Future opportunity
  • Published 1 October 2019, last edited 1 October 2019

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2020/2021 £11,250,000
2021/2022 £3,750,000

About the buyer

Address

Commercial Medicines Unit
2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

wendy.roach@nhs.net